Cargando…
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
BACKGROUND: The VHL protein (pVHL) is a multiadaptor protein that interacts with more than 30 different binding partners involved in many oncogenic processes. About 70 % of clear cell renal cell carcinoma (ccRCC) have VHL mutations with varying impact on pVHL function. Loss of pVHL function leads to...
Autores principales: | Razafinjatovo, Caroline, Bihr, Svenja, Mischo, Axel, Vogl, Ursula, Schmidinger, Manuela, Moch, Holger, Schraml, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987997/ https://www.ncbi.nlm.nih.gov/pubmed/27530247 http://dx.doi.org/10.1186/s12885-016-2688-0 |
Ejemplares similares
-
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma
por: Razafinjatovo, Caroline Fanja, et al.
Publicado: (2016) -
Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system
por: Ni, Jieming, et al.
Publicado: (2021) -
USP9X destabilizes pVHL and promotes cell proliferation
por: Zhang, Cong, et al.
Publicado: (2016) -
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients
por: Lukamowicz-Rajska, Magdalena, et al.
Publicado: (2016) -
pVHL Mediates K63-Linked Ubiquitination of nCLU
por: Xue, Jing, et al.
Publicado: (2012)